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Introduction 
Entacapone (ENT) is chemically (E)-2-cyano-3-(3, 4-
dihydroxy-5-nitrophenyl)-N,  N-diethyl-2-propenamide 
(Figure  1),  is  a  drug  that  functions  as  a  catechol-O-
methyl  transferase  (COMT)  inhibitor,  used  in  the 
treatment of Parkinson’s disease. It is a member of the 
class of nitrocatechols.
1,2 The drug is not official in any 
pharmacopoeia. Literature survey revealed few HPLC 
methods
3,4 has been reported for the determination of 
ENT in biological fluids. The reported methods for the 
determination of ENT in tablets includes HPLC
5-11 and 
spectrophotometric methods.
12,13  
As  the  environmental  pollution  it  is  necessary  to 
preclude  the  use  of  organic  solvents  for  analysis  of 
drug.  Various  techniques  have  been  employed  to 
enhance the aqueous solubility and hydrotropy is one 
of them. Hydrotropic solubilization is the phenomenon 
by  which  aqueous  solubility  of  poorly  water  soluble 
drugs and insoluble drugs increases. Maheshwari and 
Jain et al has used sodium salicylate, sodium benzoate, 
urea, nicotinamide, sodium citrate and sodium acetate 
as the most common examples of hydrotropic agents 
utilized  to  increase  the  water  solubility  of  drug.
14-19 
Various organic solvents such as methanol, chloroform, 
dimethyl  formamide  and  acetonitrile  have  been 
employed  for  solubilization  of  poorly  water-soluble 
drugs  to  carry  out  spectrophotometric  analysis. 
Drawbacks  of  organic  solvents  include  their  higher 
cost, toxicity and pollution. Hydrotropic solution may 
be  a  proper  choice  to  preclude  the  use  of  organic 
solvents.  Therefore,  it  was  thought  worthwhile  to 
employ this hydrotropic solution to extract out the drug 
from  fine  powder  of  tablets  to  carry  out 
spectrophotometric  estimation.  Present  work 
emphasizes on the quantitative estimation of ENT in 
their dosage form by UV Spectroscopic methods. 
 
Materials and Methods  
Instrument 
UV-Visible double beam spectrophotometer, Shimadzu 
model-1700  having  spectral  bandwidth  3  nm  and  of 
wavelength accuracy ±1 nm, with 1cm quartz cells was 
used. 
 
Reagents and chemicals 
Analytical pure  sample of  ENT  was  supplied  as  gift 
sample  from  Sun  Pharmaceuticals  Ind.  Ltd.  Urea 
obtained  from  Merck  Chemical  Division,  Mumbai. 
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Purpose: Analysis of drug utilized the organic solvent which are costlier, toxic and 
causing environment pollution. Hydrotropic solution may be a proper choice to preclude 
the use of organic solvents so that a simple, accurate, novel, safe and precise method has 
been  developed  for  estimation  of  poorly  water  soluble  drug  Entacapone  (Water 
Solubility-7.97e-
02 g/l). Methods: Solubility of entacapone is increased by using 8M 
Urea  as  hydrotropic  agent.  There  was  more  than  67  fold  solubility  enhanced  in 
hydrotropic solution as compare with distilled water. The entacapone (ENT) shows the 
maximum absorbance at 378 nm. At this wavelength hydrotropic agent and other tablet 
excipients do not shows any significant interference in the spectrophotometric assay. 
Results: The developed method was found to be linear in the range of 4-20 μg/ml with 
correlation coefficient (r
2) of 0.9998. The mean percent label claims of tablets of ENT in 
tablet dosage form estimated by the proposed method were found to be 99.17±0.63. The 
developed methods were validated according to ICH guidelines and values of accuracy, 
precision and other statistical analysis were found to be in good accordance with the 
prescribed values. Conclusion: As hydrotropic agent used in the proposed method so 
this method is Ecofriendly and it can be used in routine quantitative analysis of drug in 
bulk drug and dosage form in industries.  
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Reverse Osmosis (R.O.) Water was used throughout the 
study. 
 
 
Figure 1. Chemical structure of ENT 
 
Preliminary solubility studies of drugs 
An excess amount of drug was added to a screw capped 
25 ml of volumetric flask containing different aqueous 
systems  viz.  distilled  water,  different  combination  of 
hydrotropic agent. The volumetric flasks were shaken 
mechanically  for  12  hrs  at  25±1°C  in  a  mechanical 
shaker. These solutions were allowed to equilibrate for 
next 24 hrs and then centrifuged for 5 min at 2000 rpm. 
The  supernatant  liquid  was  taken  for  appropriate 
dilution  after  filtered  through  whatman  filter  paper 
no.41  and  analyzed  spectrophotometrically  against 
corresponding  solvent  blank.  After  analysis,  it  was 
found that the enhancement in the solubility of ENT 
was  to  be  more  than  and  67  folds  in  8  M  Urea  as 
compared to solubility studies in other solvents. 
 
Selection of hydrotropic agent 
ENT was scanned in hydrotropic agent in the spectrum 
mode over the UV range (200-400) and 8 M Urea as 
hydrotropic agent were found to be most appropriate 
because: 
  ENT  is soluble in  it (67  fold enhancement  of 
solubility) 
  ENT is stable in hydrotropic agent (as shown in 
Figure 2) 
  ENT exhibit good spectral characteristics in it. 
  Urea solution has no interference with the λmax 
of ENT i.e 378nm. 
 
 
Figure 2. Spectra of ENT in 8 M Urea as Hydrotropic Agent 
Establishment of stability profile 
Stability of ENT was observed by dissolving in 8 M 
Urea  as  hydrotropic  agent.  Solution  of  ENT  was 
prepared in the conc. of 12 g/ml and scanned under 
time scan for 30 min. Spectra of drug under time scan 
shows that drug are stable in hydrotropic solution. 
 
Linearity range and calibration graph 
Preparation of Standard Stock Solution (Stock-A) 
Accurately  weighed  100  mg  of  the  ENT  was 
transferred in to 100 ml volumetric flask containing 80 
ml of hydrotropic agent and the flask was sonicated for 
about 10 min to solubilize the drug and the volume was 
made up to the mark with mixed hydrotropic agent to 
get a concentration of 1000 µg/ml (Stock-A).  
 
Preparation of Working Standard Solution 
The standard solution (1000 µg/ml) was further diluted 
with distilled water to obtain 4, 8, 12, 16 and 20µg /ml 
solution and absorbance were noted at 378 nm against 
distilled water as blank.  
 
Analysis of Marketed Formulation 
Marketed formulation Entacom (Intas Pharmaceuticals) 
was selected for tablet analysis, i. e containing 200 mg 
ENT. Twenty tablets were accurately weighed, average 
weight  determined  and  ground  to  fine  powder.  An 
accurately  weighed  quantity  of  powder  equivalent  to 
100 mg of ENT was transferred into 100 ml volumetric 
flask  containing  80  ml  of  hydrotropic  solution.  The 
flask was sonicated for about 20 min to solublize the 
drug; volume was adjusted to mark with hydrotropic 
agent and filtered through whatman filter paper no. 41. 
The Absorbance of sample solutions was analyzed on 
UV spectrophotometer at 378 nm against R.O. water as 
blank.  
 
Validation Parameters 
The  developed  method  was  validated  as  per  ICH 
guidelines  (Linearity,  Accuracy,  Precision  and 
Robustness).
20 
 
Linearity 
Linearity of ENT was established by response ratios of 
drug. Response ratio of drug was calculated by dividing 
the absorbance with respective concentration. 
 
Accuracy 
To  check  the  degree  of  accuracy  of  the  method, 
recovery  studies  were  performed  in  triplicate  by 
standard addition method at 80%, 100% and 120%. In 
preanalyzed tablet solution, a definite amount of drug 
was  added  and  then  its  recovery  was  studied.  These 
studies were performed in by adding fixed amount of 
pure drug solution to the final dilution while varying 
the concentration of tablet sample solution in the final 
dilution.  
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Precision 
Precision of the methods was studied at three level as at 
repeatability, intermediate precision (Day to Day and 
analyst to analyst) and reproducibility.  
Repeatability  was  performed  by  analyzing  same  5 
concentrations of  drug for  5  times.  Day to  Day  was 
performed by analyzing 5 different concentration of the 
drug for three days in a week.  
Reproducibility  was  performed  by  analyzing  same 
concentration of drugs for five times in different lab.  
 
Results and Discussions 
Based  on  the  solubility,  stability  and  spectral 
characteristics of the drug, 8M Urea was selected as 
hydrotropic  agent.  There  was  more  than  67  fold 
solubility enhanced in hydrotropic solution as compare 
with distilled water. After solubilizing the Entacapone 
in  selected  hydrotropic  agent,  it  was  scanned  in 
spectrum  mode  and  the  working  wavelength  for  the 
estimation,  considering  the  reproducibility  and 
variability was found to be 378 nm. Spectra of ENT is 
shown  in  Figure  2,  Calibration  curve  was  plotted 
between  concentrations  versus  absorbance  Figure  3. 
Observation of linearity data has reported in the Table 
1. The Result of their optical characteristics has been 
reported in Table 2.The developed method was found 
to  be  linear  in  the  range  of  4-20  μg/ml  with  linear 
equation  was  Y=0.098X  +  0.011  and  correlation 
coefficient  (r
2)  of  0.9998.  Drug  content  of  tablet 
formulation was calculated using calibration curve and 
values are reported in Table 3. The mean percent label 
claims of tablets of ENT in formulation-I estimated by 
the  proposed  method  were  found  to  be  99.17±0.63. 
These values are close to 100, indicating the accuracy 
of the proposed analytical method.  
 
 
Figure 3. Calibration Curve of ENT at 378 nm in 8 M Urea 
 
Table 1. Linearity ENT at λmax =378 nm in 8 M Urea 
Standard Conc. (g/ml)  Rep-1  Rep-2  Rep-3  Rep-4  Rep-5  Mean 
0  0  0  0  0  0  0 
4  0.403  0.408  0.41  0.411  0.401  0.4066 
8  0.821  0.823  0.812  0.841  0.842  0.8278 
12  1.182  1.193  1.195  1.184  1.185  1.1878 
16  1.586  1.593  1.554  1.579  1.599  1.5822 
20  1.976  1.996  1.99  1.986  1.988  1.9872 
Correlation Coefficient (r
2)  -  -  -  -  -  0.9998 
Slope (m)  -  -  -  -  -  0.0987 
Intercept (c)  -  -  -  -  -  0.0113 
 
 
Table 2. Optical Characteristic and Linearity Data of ENT in 8 
M Urea 
S. No.  Parameter 
8 M Urea as 
Hydrotropic Agent 
1  Working λ  378 nm 
2  Beer’s law limit (μg/ml)  4-20 
3  Correlation Coefficient (r
2)*  0.9998 
4  Slope (m)*  0.098 
5  Intercept (c)*  0.011 
6  Number of samples (n)  25 
*Average of 5 determination of 5 concentrations 
 
Result of Validation Parameters 
Linearity 
Linearity was established in the range of 4-20μg/ml and 
it was reported as response ratio; Table 4. Then a graph 
was plotted between concentration and response ratio 
(Figure 4) which assure the linearity of the method. 
 
Accuracy 
The  values  of  mean  percentage  recoveries  were  also 
found to show variability in ranging from 97.83±1.03 
to  98.92±0.82%.  Low  values  of  standard  deviation, 
percent  coefficient  of  variation  and  standard  error 
further validated the proposed method (Table 5). All 
these values were very close to 100.  
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Table 3. Results and Statistical Parameters for Entacom 200 mg Tablet Analysis using 8M Urea 
Drug  Label Claim (mg)  Amount Found (mg)  % MEAN*  S.D.*  %COV*  Std. Error* 
Entacom200  200  198.67  99.33  0.26  0.262  0.048 
Entacom200  200  198.43  99.21  0.73  0.736  0.133 
Entacom200  200  197.93  98.96  0.89  0.899  0.163 
Mean  -  198.34  99.17  0.63  0.632  0.115 
*Average of five in 3 replicates determination 
 
 
Table 4. Response Ratio of ENT in Hydrotropic Solution 
S. No. 
8 M Urea as Hydrotropic Agent 
Conc. (µg/ml)  ABS  Response Ratio 
1.  4  0.402  0.10 
2.  8  0.81  0.10 
3.  12  1.194  0.10 
4.  16  1.584  0.10 
5.  20  1.99  0.10 
 
Figure 4. Response Ratio Curve of ENT in 8 M Urea 
 
Table 5. Result of Recovery Studies of Tablet Formulation with Statically Evaluation 
Drug  QC Conc. (μg/ml) 
Recovery Level % 
(Amount Drug Added) 
Amount of Drug Found 
(Mean±SD)* 
% RSD 
ENT  10  80  98.47±1.23  0.332 
-  -  100  98.39±1.08  0.447 
-  -  120  97.83±1.03  0.40 
ENT  12  80  98.86±0.63  0.90 
-  -  100  98.92±0.82  0.30 
-  -  120  98.29±0.74  0.63 
*Average of five determination 
 
Precision 
Result  of  precision  at  different  level  were  found  be 
within  acceptable  limits  (RSD<2).  The  results  have 
been reported in Table 6. Presence of hydrotropic agent 
do  not  shows  any  significant  interference  in  the 
spectrophotometric  assay  thus  further  confirming  the 
applicability  and  reproducibility  of  the  developed 
method. 
 
Table 6. Result of Precision of ENT 
-  Validation Parameter  Percentage Mean ± S.D*. (n=6)  Percentage RSD 
With 8 M Urea as Hydrotropic Agent 
Repeatability   98.64±1.31  1.33 
Intermediate Precision  -  - 
-  Day to Day  98.92±1.42  1.435 
-  Analyst to Analyst  98.74±0.86  0.870 
-  Reproducibility  98.39±0.70  0.711 
-  -  -  - 
* Mean of fifteen determinations (3 replicates at 5 concentrations level) 
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Conclusion 
Hence, it is concluded that the proposed methods are 
new, simple, cost effective, accurate, safe and precise 
and  can  be  successfully  employed  in  the  routine 
analysis of Entacapone in bulk drug sample and tablet 
dosage form. Advantage of these methods is that the 
organic  solvent  is  not  essential  for  the  analysis  and 
there  was  no  interference  of  8  M  urea  during  the 
estimation.  There  is  a  good  scope  for  other  poorly 
water‐soluble  drugs  which  may  be  tried  to  get 
solubilized in 2 M urea solution (as hydrotropic agent) 
to carry out their spectrophotometric analysis excluding 
the use of costlier and unsafe organic solvents.  
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